History
  • No items yet
midpage
Hermelin v. K-V Pharmaceutical Co.
54 A.3d 1093
Del. Ch.
2012
Read the full case

Background

  • Hermelin seeks advancement and indemnification from KV under an Indemnification Agreement and DGCL provisions for several regulatory and criminal matters.
  • The matters include Audit Committee Matter, Criminal Matter, FDA Consent Decree Matter, and HHS Exclusion Matter; two other matters are settled and KV has agreed not to claw back amounts.
  • KV argues some claims are excluded by contract (3(b)(iv)) or unresolved as to mandatory indemnification; Hermelin contends he is entitled to advancement for several reasons.
  • The Jail Records Matter (injunctive relief related to jail-recordings) seeks advancement but the court finds the Indemnification Agreement excludes advancement for matters initiated by the indemnitee, and Hermelin initiated this action.
  • The court resolves the scope of mandatory indemnification (FDA Consent Decree Matter yes; Criminal and HHS Exclusion Matters no) and limits permissive indemnification discovery to the conduct underlying the relevant proceedings.
  • Discovery and potential plenary trial are reserved for good-faith questions under Section 145(a) for permissive indemnification.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Advancement for Jail Records Matter allowed? Hermelin argues it is defense-related and not initiated by him. Section 3(b)(iv) excludes advancement for any matter initiated by the indemnitee. Advancement for Jail Records Matter denied
Mandatory indemnification outcomes for the four proceedings Hermelin seeks mandatory indemnification where successful on the merits or otherwise. KV argues only FDA Consent Decree matter shows 'success on the merits'; others do not. FDA Consent Decree Matter yields mandatory indemnification; Criminal Matter and HHS Exclusion Matter do not
Scope of evidence for permissive indemnification (good faith) discovery Discovery should cover broad conduct related to underlying proceedings. Discovery limited to good-faith conduct related to the pertinent proceedings. Discovery limited to conduct underlying the proceedings; plenary trial required for good-faith issue; scope narrowed
Effect of 3(b)(iv) exclusion on advancement and good-faith analysis 3(b)(iv) should not bar advancement for compelled defenses or injunctive actions. 3(b)(iv) excludes advancement for any proceeding initiated by the indemnitee, including jail-records matter. 3(b)(iv) applies; advancement denied for Jail Records Matter

Key Cases Cited

  • Merritt-Chapman & Scott Corp. v. Wolfson, 321 A.2d 138 (Del. Super. Ct. 1974) (success in criminal plea context evaluated by outcome, not morality)
  • Waltuch v. Conticommodity Servs., Inc., 88 F.3d 87 (2d Cir. 1996) (standard for 'success on the merits' and indemnification limits)
  • United States v. Dotterweich, 320 U.S. 277 (S. Ct. 1943) (RCO doctrine; corporate officers liable for FDCA violations)
Read the full case

Case Details

Case Name: Hermelin v. K-V Pharmaceutical Co.
Court Name: Court of Chancery of Delaware
Date Published: Feb 7, 2012
Citation: 54 A.3d 1093
Docket Number: Civil Action No. 6936-VCG
Court Abbreviation: Del. Ch.